These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 15451836)
1. Limitations to antiarrhythmic drug use in patients with atrial fibrillation. Humphries KH; Kerr CR; Steinbuch M; Dorian P; CMAJ; 2004 Sep; 171(7):741-5. PubMed ID: 15451836 [TBL] [Abstract][Full Text] [Related]
2. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638 [TBL] [Abstract][Full Text] [Related]
3. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management. Gillis AM; Verma A; Talajic M; Nattel S; Dorian P; Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862 [TBL] [Abstract][Full Text] [Related]
4. Atrial fibrillation: rate control often better than rhythm control. Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984 [TBL] [Abstract][Full Text] [Related]
5. Treatment of resistant atrial fibrillation. A meta-analysis comparing amiodarone and flecainide. Zarembski DG; Nolan PE; Slack MK; Caruso AC Arch Intern Med; 1995 Sep; 155(17):1885-91. PubMed ID: 7677555 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation. Kosior D; Opolski G; Torbicki A Med Sci Monit; 2001; 7(1):68-73. PubMed ID: 11208496 [TBL] [Abstract][Full Text] [Related]
7. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. Pappone C; Augello G; Sala S; Gugliotta F; Vicedomini G; Gulletta S; Paglino G; Mazzone P; Sora N; Greiss I; Santagostino A; LiVolsi L; Pappone N; Radinovic A; Manguso F; Santinelli V J Am Coll Cardiol; 2006 Dec; 48(11):2340-7. PubMed ID: 17161267 [TBL] [Abstract][Full Text] [Related]
8. Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation. Freemantle N; Lafuente-Lafuente C; Mitchell S; Eckert L; Reynolds M Europace; 2011 Mar; 13(3):329-45. PubMed ID: 21227948 [TBL] [Abstract][Full Text] [Related]
9. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. Roy D; Talajic M; Dorian P; Connolly S; Eisenberg MJ; Green M; Kus T; Lambert J; Dubuc M; Gagné P; Nattel S; Thibault B N Engl J Med; 2000 Mar; 342(13):913-20. PubMed ID: 10738049 [TBL] [Abstract][Full Text] [Related]
10. An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation. Brignole M; Menozzi C; Gasparini M; Bongiorni MG; Botto GL; Ometto R; Alboni P; Bruna C; Vincenti A; Verlato R; Eur Heart J; 2002 Jun; 23(11):892-900. PubMed ID: 12042011 [TBL] [Abstract][Full Text] [Related]
11. Management of patients with acute atrial fibrillation in the ED. Conti A; Del Taglia B; Mariannini Y; Pepe G; Vanni S; Grifoni S; Abbate R; Michelucci A; Padeletti L; Gensini GF Am J Emerg Med; 2010 Oct; 28(8):903-10. PubMed ID: 20825922 [TBL] [Abstract][Full Text] [Related]
12. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Valembois L; Audureau E; Takeda A; Jarzebowski W; Belmin J; Lafuente-Lafuente C Cochrane Database Syst Rev; 2019 Sep; 9(9):CD005049. PubMed ID: 31483500 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium]. Márk L; Erdej F; Dani G; Borbély M; Sziklai G; Nagy E; Hajdara I; Katona A Orv Hetil; 2004 May; 145(19):1001-6. PubMed ID: 15181735 [TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease. Allen LaPointe NM; Dai D; Thomas L; Piccini JP; Peterson ED; Al-Khatib SM Am J Cardiol; 2015 Feb; 115(3):316-22. PubMed ID: 25491240 [TBL] [Abstract][Full Text] [Related]
15. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial. Auer J; Weber T; Berent R; Puschmann R; Hartl P; Ng CK; Schwarz C; Lehner E; Strasser U; Lassnig E; Lamm G; Eber B; Am Heart J; 2004 Apr; 147(4):636-43. PubMed ID: 15077078 [TBL] [Abstract][Full Text] [Related]
16. [Therapy of atrial fibrillation with class III anti-arrhythmia agents]. Follath F; Candinas R; Frielingsdorf J Herz; 1993 Feb; 18(1):20-6. PubMed ID: 8454249 [TBL] [Abstract][Full Text] [Related]
17. Pharmacologic conversion of atrial fibrillation: a systematic review of available evidence. Slavik RS; Tisdale JE; Borzak S Prog Cardiovasc Dis; 2001; 44(2):121-52. PubMed ID: 11568824 [TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic therapy and risk of death in patients with atrial fibrillation: a nationwide study. Andersen SS; Hansen ML; Gislason GH; Schramm TK; Folke F; Fosbøl E; Abildstrøm SZ; Madsen M; Køber L; Torp-Pedersen C Europace; 2009 Jul; 11(7):886-91. PubMed ID: 19443433 [TBL] [Abstract][Full Text] [Related]
19. Serial antiarrhythmic therapy: role of amiodarone in prevention of atrial fibrillation recurrence--a lesson from the HOT CAFE Polish Study. Kosior DA; Opolski G; Wozakowska-Kaplon B; Rabczenko D; Cardiology; 2005; 104(1):35-44. PubMed ID: 15942183 [TBL] [Abstract][Full Text] [Related]
20. [Antiarrhythmic treatment after reduction of atrial fibrillation by external shock]. Koenig A; Theolade R; Chauvin M; Brechenmacher C Presse Med; 1993 Nov; 22(36):1827-32. PubMed ID: 8309912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]